ANI Pharma Inc (ANIP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 144,894 | 221,121 | 53,234 | 100,300 | 7,864 |
| Marketable Securities | 6,307 | 0 | N/A | N/A | N/A |
| Receivables | 221,726 | 162,079 | 165,438 | 128,526 | 95,793 |
| Inventories | 136,782 | 111,196 | 105,355 | 81,693 | 60,803 |
| Other current assets | 0 | 8,020 | 8,020 | 0 | 0 |
| TOTAL | $527,684 | $519,816 | $344,261 | $321,775 | $170,321 |
| Non-Current Assets | |||||
| PPE Net | 56,863 | 44,593 | 43,246 | 52,671 | 41,269 |
| Intangibles | 601,824 | 237,230 | 279,856 | 322,010 | 192,091 |
| Other Non-Current Assets | 97,326 | 102,783 | 92,724 | 75,142 | 57,509 |
| TOTAL | $756,013 | $384,606 | $415,826 | $449,823 | $290,869 |
| Total Assets | $1,283,697 | $904,422 | $760,087 | $771,598 | $461,190 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 9,172 | 850 | 850 | 850 | 13,243 |
| Accounts payable and accrued liabilities | 45,656 | 36,683 | 29,305 | 22,967 | 11,261 |
| Accrued Expenses | 132,074 | 87,514 | 69,284 | 63,720 | 50,075 |
| Other current liabilities | 29 | 12,266 | 0 | N/A | N/A |
| TOTAL | $193,680 | $145,477 | $99,439 | $87,537 | $78,565 |
| Non-Current Liabilities | |||||
| Long Term Debt | 309,108 | 284,819 | 285,669 | 286,520 | 172,443 |
| Deferred Revenues | N/A | N/A | N/A | N/A | 80 |
| Other Non-Current Liabilities | 352,379 | 16,527 | 36,439 | 38,801 | 14,482 |
| TOTAL | $661,487 | $301,346 | $322,108 | $325,321 | $186,925 |
| Total Liabilities | $855,167 | $446,823 | $421,547 | $412,858 | $265,490 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 21,774 | 21,079 | 17,504 | 17,272 | 12,365 |
| Common Shares | 2 | 2 | 1 | 1 | 1 |
| Retained earnings | -100,279 | -80,132 | -97,286 | -47,765 | -4,972 |
| Other shareholders' equity | 30,154 | 33,626 | 36,924 | 21,660 | -11,683 |
| TOTAL | $428,530 | $457,599 | $338,540 | $358,740 | $195,700 |
| Total Liabilities And Equity | $1,283,697 | $904,422 | $760,087 | $771,598 | $461,190 |